---
figid: PMC3539972__pone.0053518.g001
figtitle: AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human
  AML to Gemtuzumab Ozogamicin
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3539972
filename: pone.0053518.g001.jpg
figlink: /pmc/articles/PMC3539972/figure/pone-0053518-g001/
number: F1
caption: 'Scheme depicts the presumed mechanism of action of GO in CD33+ AML cells
  , . Experimentally measured components in our studies are shown in red: CD33 expression
  levels; drug efflux pump activity; γH2AX (extent of DNA damage); survival signaling
  pathways (PI3K/AKT, MEK/ERK, and JAK/STAT pathway); and cleaved PARP and cell membrane
  integrity (apoptosis/cell death).'
papertitle: AKT Signaling as a Novel Factor Associated with In Vitro Resistance of
  Human AML to Gemtuzumab Ozogamicin.
reftext: David B. Rosen, et al. PLoS One. 2013;8(1):e53518.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.963126
figid_alias: PMC3539972__F1
figtype: Figure
redirect_from: /figures/PMC3539972__F1
ndex: 4d692cb9-ded5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3539972__pone.0053518.g001.html
  '@type': Dataset
  description: 'Scheme depicts the presumed mechanism of action of GO in CD33+ AML
    cells , . Experimentally measured components in our studies are shown in red:
    CD33 expression levels; drug efflux pump activity; γH2AX (extent of DNA damage);
    survival signaling pathways (PI3K/AKT, MEK/ERK, and JAK/STAT pathway); and cleaved
    PARP and cell membrane integrity (apoptosis/cell death).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Go
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - MRP
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - lok
  - Decay
  - Parp
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - CD33
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CD9
  - ABCB1
  - TBC1D9
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - CHEK2
  - CASP3
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
---
